We are live on ! Find out more
DTC

Deep Track Capital Portfolio holdings

AUM $6.12B
1-Year Est. Return 144%
This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
+144%
3 Year Est. Return
+348.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.35B
AUM Growth
-$141M
Cap. Flow
+$96.9M
Cap. Flow %
2.89%
Top 10 Hldgs %
41.69%
Holding
77
New
11
Increased
22
Reduced
20
Closed
9

Top Buys

Rank Stock Value
1
IMVT icon
Immunovant
IMVT
+$68M
2
APLS
Apellis Pharmaceuticals
APLS
+$67.9M
3
TGTX icon
TG Therapeutics
TGTX
+$45.8M
4
KRRO icon
Korro Bio
KRRO
+$42.6M
5
AXSM icon
Axsome Therapeutics
AXSM
+$40.6M

Top Sells

Rank Stock Value
1
INSM icon
Insmed
INSM
+$108M
2
GERN icon
Geron
GERN
+$68.2M
3
APGE icon
Apogee Therapeutics
APGE
+$64.2M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$52.5M
5
TRML
Tourmaline Bio
TRML
+$36.5M

Sector Composition

Rank Sector Weight
1 Healthcare 99.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRML
76
DELISTED
Tourmaline Bio
TRML
– –
-1,595,400
Closed -$36.5M
ITCI
77
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-175,400
Closed -$12.1M
1 2 3
4

Similar funds

AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

Deep Track Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Deep Track Capital held 77 positions worth $3.35B, down 4% from $3.49B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Deep Track Capital's Q2 2024 filing shows 11 new, 22 increased, 20 reduced and 9 closed positions. Its largest new stake was TG Therapeutics: 2,870,131 shares worth $51.1M. The largest sale was Insmed, an estimated $108M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier.

  • Deep Track Capital's largest Q2 2024 buy was TG Therapeutics: 2,870,131 shares worth $51.1M.
  • Deep Track Capital added most to Immunovant in Q2 2024, an estimated $68M increase.
  • Deep Track Capital's biggest Q2 2024 reduction was Insmed, cutting an estimated $108M.
  • Deep Track Capital fully exited Tourmaline Bio in Q2 2024, selling an estimated $36.5M.
  • Deep Track Capital's ten largest holdings make up 42% of its $3.35B portfolio in Q2 2024.
  • Deep Track Capital opened 11 new positions and closed 9 in Q2 2024.
  • Deep Track Capital's portfolio value fell 4% quarter-over-quarter to $3.35B.

Based on Deep Track Capital's 13F filing for Q2 2024, filed 14 Aug 2024.